
To identify the zzso of zzso responses to zzso influenza zzso vaccines in a cohort of cancer zzso 

Patients with cancer and controls were enrolled in a prospective zzso field zzso Two doses of zzso pandemic influenza vaccine were administered to patients and one dose was administered to zzso zzso responses were measured using zzso zzso and confirmed by zzso Geometric mean zzso zzso and zzso rates zzso as zzso zzso were zzso 

zzso were safe and well tolerated in 197 cancer patients zzso zzso zzso zzso lung or head and neck, zzso zzso zzso breast, zzso and 138 zzso Similar zzso rates zzso versus zzso and zzso zzso versus zzso were achieved after two doses of zzso vaccine in cancer patients and one dose in zzso zzso analyses identified older age, prior zzso against seasonal zzso lymphoma, zzso count, active chemotherapy, and zzso and steroid treatments as being associated with weaker zzso zzso However, only age and chemotherapy plus zzso remained independent zzso of vaccine responses in zzso zzso 

Two doses of zzso influenza vaccine zzso potent zzso responses in most cancer patients despite ongoing chemotherapy, with the exception of zzso zzso zzso Oncology patients treated in an zzso setting benefit from preventive vaccination against influenza with zzso zzso 

